Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death

Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death

Item

http://www.wikidata.org/entity/Q34015840

Q34015840

about

Mechanism of dichotomy between CD8+ responses elicited by apoptotic and necrotic cells Adoptive T cell therapy: Addressing challenges in cancer immunotherapy Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes Chimeric antigen receptor therapy for cancer Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy.mRNA Structural constraints on EBNA1 synthesis impact on in vivo antigen presentation and early priming of CD8+ T cells.Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naïve and malaria-exposed individuals.Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response.Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.Supernatural T cells: genetic modification of T cells for cancer therapy.Adoptive T-cell transfer in cancer immunotherapy.Genetic modification of T cells for immunotherapy.Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.Maternal and early life stress effects on immune function: relevance to immunotoxicology.Current status of chimeric antigen receptor therapy for haematological malignancies.Rapamycin results in Bim-mediated loss of thymic regulatory T cells during development in organ culture.Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity.Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy.The Quantity of Autocrine IL-2 Governs the Expansion Potential of CD8+ T Cells.CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice.A carbon nanotube-polymer composite for T-cell therapy.

P2860

Q24629263-09C02AA6-1F0C-48FB-B67F-4EA11C743080 Q24805804-E6DFED99-6C20-4B90-A67F-3903A48D89A1 Q26770386-1622D687-74CD-487F-B0B2-303E82013206 Q27013599-6C5F8AAF-F842-4E92-B1F2-81D024B4D01F Q34196228-0A157005-D1FF-4823-80A8-384DB4903A46 Q34257060-80928A1A-2972-43D7-95D6-ADF125F6E3A7 Q34317937-0A46F742-AF2E-4FC0-819B-AFAC11325F87 Q35001627-452F95FC-DE15-4ACA-A3A0-A4E02E1F8AE6 Q35217534-9D2284A0-DB09-485B-85E7-0BB8BDB4DCFB Q35828752-57587F86-3898-415A-854C-A4C07A37E8D7 Q36239656-0A1C262A-FA1A-4AB1-9A43-0FC81FA280EC Q36328805-DEA7CF87-1FE7-48E1-BE7B-1D9B7DD254DB Q36471818-BBD3EEB0-5C53-4C5C-B3BF-0EC57196F9F7 Q36909362-8014F700-3BB5-4514-84CB-B7DAAC240C2B Q37257207-87CEEDE1-208B-4BB3-B838-9189764AEB02 Q37464980-35030CE0-E702-404F-B7AB-F29EBF050AD7 Q38631108-49C7B262-F983-4322-8C4D-225EFA136B77 Q39637282-CA65E92E-CCF0-4B64-BE34-CB73D1FDC0AE Q41822355-58B88C25-5A8D-4CBC-92D5-E03CEEB30C4B Q47259954-66BE5736-8DB7-487A-8540-712458191E26 Q48121576-18A86F44-0516-4757-98BD-7B07BFD4CC9B Q48216696-DE5D3CED-5738-4737-B9B7-E0A0E9B9ECC2 Q53482969-CF3D136F-69B9-4C73-BBDD-54B78B7BB4A7

P2860

Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death

Item

http://www.wikidata.org/entity/Q34015840

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu